Polymerase Chain Reaction on Respiratory Tract Specimens of Immunocompromised Patients to Diagnose Pneumocystis Pneumonia: A Systematic Review and Meta-analysis
- Author: mycolabadmin
- 6/11/2024
- View Source
Summary
This study analyzed how well PCR tests detect Pneumocystis pneumonia, a serious fungal lung infection in immunocompromised patients. The research reviewed 55 studies with over 11,000 tests and found that PCR testing of fluid from the lungs or induced sputum works very well, especially at ruling out the disease when negative. However, positive test results need careful interpretation because the test can detect the fungus even when it’s just colonizing rather than causing active infection.
Background
Pneumocystis pneumonia (PCP) occurs in immunocompromised patients including those with advanced HIV infection and other conditions requiring immunosuppression. PCR-based methods have been developed for PCP diagnosis but lack standardization and clear interpretation criteria to distinguish colonization from active infection.
Objective
To examine the comparative diagnostic performance of polymerase chain reaction (PCR) and different sampling approaches for PCP diagnosis in both HIV and non-HIV populations using proven PCP as the reference standard.
Results
qPCR on bronchoalveolar lavage fluid (BALF) achieved highest sensitivity of 98.7% with specificity of 89.3%. qPCR on induced sputum provided similar sensitivity of 98.0% but reduced specificity of 81.5%. No significant differences in sensitivity and specificity were found between HIV and non-HIV populations.
Conclusion
qPCR on deeper respiratory tract specimens provides high diagnostic performance for excluding PCP when negative. PCR positivity requires clinical interpretation considering fungal burden, specimen type, and patient population. These findings provide a framework for clinicians interpreting different PCR testing results and sampling approaches.
- Published in:Clinical Infectious Diseases,
- Study Type:Systematic Review and Meta-analysis,
- Source: PMID: 38860786, DOI: 10.1093/cid/ciae239